Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Phenylephrine in Cardiac Surgery
NCT04602767Phase 4Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Oct 2020
- Primary completion
- May 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of vasopressin in acute kidney injury (AKI), sponsored by Thomas Jefferson University. Started Oct 2020; status: recruiting.
02
Drugs
vasopressin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04602767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04602767.